Tag: nasdaq:rckt
March 11, 2020
Forty Seven and Rocket Collaborate for Fanconi Anemia Research
Forty Seven and Rocket have entered into a research collaboration to pursue clinical proof-of-concept for Forty Seven’s novel conditioning regimen... March 5, 2020
Rocket Pharmaceuticals Reports Full Year 2019 Financial Results
Rocket reports financial results for the year ended December 31, 2019, and provides an update on the company's recent pipeline...
October 16, 2019
Biotech Market Update: Q3 2019 in Review
With Q3 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends... September 10, 2019
Rocket Pharmaceuticals Announces Data from Phase 1/2 Trial of RP-L102
Rocket Pharmaceuticals (NASDAQ:RCKT) has announced the publication of long-term data from its ongoing Phase 1/2 trial of RPL-102, the company’s...
November 19, 2018
Rocket Pharmaceuticals Receives FDA Drug Clearance
The company’s drug, PR-L201, is in development to treat Leukocyte Adhesion Deficiency-I, a rare pediatric disease. November 19, 2018